Helicobacter pylori Infection as a Predictor of Treatment Outcomes of Gastric Cancer: A Systematic Review and Meta-Analysis

2.

Fornaro

L

,

Vasile

E

,

Aprile

G

,

Goetze

TO

,

Vivaldi

C

,

Falcone

A

.

Locally advanced gastro-oesophageal cancer: recent therapeutic advances and research directions

.

Cancer Treat Rev

.

2018 Sep

69

90

100

.

3.

Smyth

EC

,

Verheij

M

,

Allum

W

,

Cunningham

D

,

Cervantes

A

,

Arnold

D

.

Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up

.

Ann Oncol

.

2016 Sep

27

Suppl 5

v38

49

.

4.

Rausei

S

,

Lianos

GD

.

Treatment of gastric cancer

.

Cancers

.

2020 Sep 15

12

9

2627

.

5.

Ito

N

,

Tsujimoto

H

,

Ueno

H

,

Xie

Q

,

Shinomiya

N

.

Helicobacter pylori-mediated immunity and signaling transduction in gastric cancer

.

J Clin Med

.

2020 Nov 18

9

11

3699

.

6.

Alipour

M

.

Molecular mechanism of Helicobacter pylori-induced gastric cancer

.

J Gastrointest Cancer

.

2021 Mar

52

1

23

30

.

7.

Wang

F

,

Sun

G

,

Zou

Y

,

Zhong

F

,

Ma

T

,

Li

X

.

Protective role of Helicobacter pylori infection in prognosis of gastric cancer: evidence from 2,454 patients with gastric cancer

.

PLoS One

.

2013 May 7

8

5

e62440

.

8.

Fang

X

,

Liu

K

,

Cai

J

,

Luo

F

,

Yuan

F

,

Chen

P

.

Positive Helicobacter pylori status is associated with better overall survival for gastric cancer patients: evidence from case-cohort studies

.

Oncotarget

.

2017 Oct 3

8

45

79604

17

.

9.

Jia

Z

,

Zheng

M

,

Jiang

J

,

Cao

D

,

Wu

Y

,

Zhang

Y

.

Positive H. pylori status predicts better prognosis of non-cardiac gastric cancer patients: results from cohort study and meta-analysis

.

Bmc Cancer

.

2022 Feb 8

22

1

155

.

10.

Tierney

JF

,

Stewart

LA

,

Ghersi

D

,

Burdett

S

,

Sydes

MR

.

Practical methods for incorporating summary time-to-event data into meta-analysis

.

Trials

.

2007 Jun 7

8

16

.

11.

Lee

WJ

,

Lin

JT

,

Shun

CT

,

Lee

WC

,

Yu

SC

,

Lee

PH

.

Comparison between resectable gastric adenocarcinomas seropositive and seronegative for Helicobacter pylori

.

Br J Surg

.

1995

;

82

(

6

):

802

–

5

.

12.

Meimarakis

G

,

Winter

H

,

Assmann

I

,

Kopp

R

,

Lehn

N

,

Kist

M

.

Helicobacter pylori as a prognostic indicator after curative resection of gastric carcinoma: a prospective study

.

Lancet Oncol

.

2006

;

7

(

3

):

211

–

22

.

13.

Marrelli

D

,

Pedrazzani

C

,

Berardi

A

,

Corso

G

,

Neri

A

,

Garosi

L

.

Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer

.

Cancer

.

2009 May 15

115

10

2071

80

.

14.

Qiu

HB

,

Zhang

LY

,

Keshari

RP

,

Wang

GQ

,

Zhou

ZW

,

Xu

DZ

.

Relationship between H.Pylori infection and clinicopathological features and prognosis of gastric cancer

.

BMC Cancer

.

2010 Jul 17

10

1

374

.

15.

Gan

L

,

Zhang

X

,

Pan

J

,

Liu

K

,

Li

P

,

Wang

X

.

Helicobacter pylori infection status as a prognostic indicator for gastric cancer

.

Acad J Second Mil Med Univ

.

2011

;

32

(

12

):

1300

–

5

.

16.

Santos

RS

,

Lourenço

JE

,

Herbella

FA

,

del Grande

JC

,

Patti

MG

.

Helicobacter pylori has no influence on distal gastric cancer survival

.

Arq Gastroenterol

.

2011

;

48

(

2

):

109

–

11

.

17.

Choi

IK

,

Sung

HJ

,

Lee

J-H

,

Kim

JS

,

Seo

JH

.

The relationship between Helicobacter pylori infection and the effects of chemotherapy in patients with advanced or metastatic gastric cancer

.

Cancer Chemother Pharmacol

.

2012 Oct

70

4

555

8

.

18.

Hur

H

,

Lee

SR

,

Xuan

Y

,

Kim

YB

,

Lim

YA

,

Cho

YK

.

The Effects of Helicobacter pylori on the prognosis of patients with curatively resected gastric cancers in a population with high infection rate

.

J Korean Surg Soc

.

2012 Oct

83

4

203

11

.

19.

Kang

SY

,

Han

JH

,

Ahn

MS

,

Lee

HW

,

Jeong

SH

,

Park

JS

.

Helicobacter pylori infection as an independent prognostic factor for locally advanced gastric cancer patients treated with adjuvant chemotherapy after curative resection

.

Int J Cancer

.

2012 Feb 15

130

4

948

58

.

20.

Li

G

,

Wang

Z

,

Wang

Z

,

Xu

J

,

Cui

J

,

Cai

S

.

Gastric cancer patients with Helicobacter pylori infection have a poor prognosis

.

J Surg Oncol

.

2013 Dec

108

7

421

6

.

21.

Wang

F

,

Sun

GP

,

Zou

YF

,

Zhong

F

,

Ma

T

,

Li

XQ

.

Helicobacter pylori infection predicts favorable outcome in patients with gastric cancer

.

Curr Oncol

.

2013 Oct

20

5

e388

95

.

22.

Posteraro

B

,

Persiani

R

,

Dall’Armi

V

,

Biondi

A

,

Arzani

D

,

Sicoli

F

.

Prognostic factors and outcomes in Italian patients undergoing curative gastric cancer surgery

.

Eur J Surg Oncol

.

2014 Mar

40

3

345

51

.

23.

Postlewait

LM

,

Squires

MH

III,

Kooby

DA

,

Poultsides

GA

,

Weber

SM

,

Bloomston

M

.

Preoperative Helicobacter pylori infection is associated with increased survival after resection of gastric adenocarcinoma

.

Ann Surg Oncol

.

2016 Apr

23

4

1225

33

.

24.

Jung

DH

,

Lee

YC

,

Kim

JH

,

Chung

H

,

Park

JC

,

Shin

SK

.

Postoperative Helicobacter pylori infection as a prognostic factor for gastric cancer patients after curative resection

.

Gut Liver

.

2017 Sep

11

5

635

41

.

25.

Kolb

JM

,

Ozbek

U

,

Harpaz

N

,

Holcombe

RF

,

Ang

C

.

Effect of Helicobacter pylori infection on outcomes in resected gastric and gastroesophageal junction cancer

.

J Gastrointest Oncol

.

2017

;

8

(

3

):

583

–

8

.

26.

Tsai

KF

,

Liou

JM

,

Chen

MJ

,

Chen

CC

,

Kuo

SH

,

Lai

IR

.

Distinct clinicopathological features and prognosis of Helicobacter pylori negative gastric cancer

.

PLoS One

.

2017 Feb 2

12

2

e0170942

.

27.

Nishizuka

SS

,

Tamura

G

,

Nakatochi

M

,

Fukushima

N

,

Ohmori

Y

,

Sumida

C

.

Helicobacter pylori infection is associated with favorable outcome in advanced gastric cancer patients treated with S-1 adjuvant chemotherapy

.

J Surg Oncol

.

2018 Apr 1

117

5

947

56

.

28.

Fang

WL

,

Huang

KH

,

Chang

SC

,

Lin

CH

,

Chen

MH

,

Chao

Y

.

Comparison of the clinicopathological characteristics and genetic alterations between patients with gastric cancer with or without Helicobacter pylori infection

.

Oncologist

.

2019 Sep

24

9

e845

53

.

29.

Kayapinar

AK

,

Solakoglu

D

,

Bas

K

,

Oymaci

E

,

Isbilen

B

,

Calik

B

.

Relationship of prognostic factors in stomach cancer with helicobacter pylori: a retrospective study

.

Acta Gastroenterol Belg

.

2021 Oct-Dec

84

4

607

17

.

30.

Koizumi

Y

,

Ahmad

S

,

Ikeda

M

,

Yashima-Abo

A

,

Espina

G

,

Sugimoto

R

.

Improved survival by Helicobacter pylori-modulated immunity in gastric cancer patients with S-1 adjuvant chemotherapy

.

medRxiv

.

2022

;

114

(

8

):

1149

–

58

.

31.

Li

G

,

Yu

S

,

Xu

J

,

Zhang

X

,

Ye

J

,

Wang

Z

.

The prognostic role of Helicobacter pylori in gastric cancer patients: a meta-analysis

.

Clin Res Hepatol Gastroenterol

.

2019 Apr

43

2

216

24

.

32.

Zepeda-Najar

C

,

Palacios-Astudillo

RX

,

Chávez-Hernández

JD

,

Lino-Silva

LS

,

Salcedo-Hernández

RA

.

Prognostic impact of microsatellite instability in gastric cancer

.

Contemp Oncol

.

2021

;

25

(

1

):

68

–

71

.

33.

Polom

K

,

Marano

L

,

Marrelli

D

,

De Luca

R

,

Roviello

G

,

Savelli

V

.

Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer

.

Br J Surg

.

2018 Feb

105

3

159

67

.

34.

Ratti

M

,

Lampis

A

,

Hahne

JC

,

Passalacqua

R

,

Valeri

N

.

Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches

.

Cell Mol Life Sci

.

2018 Nov

75

22

4151

62

.

35.

Callery

MP

.

Helicobacter pylori in gastric cancer: friend or foe

.

Gastroenterology

.

2006 Sep

131

3

966

7

.

36.

Algood

HMS

.

T cell cytokines impact epithelial cell responses during Helicobacter pylori infection

.

J Immunol

.

2020 Mar 15

204

6

1421

8

.

37.

Valle

JK

,

Kekki

M

,

Sipponen

P

,

Ihamäki

T

,

Siurala

M

.

Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study

.

Scand J Gastroenterol

.

1996 Jun

31

6

546

50

.

38.

Kokkola

A

,

Kosunen

TU

,

Puolakkainen

P

,

Sipponen

P

,

Harkonen

M

,

Laxen

F

.

Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis

.

APMIS

.

2003 Jun

111

6

619

24

.

39.

Kishikawa

H

,

Ojiro

K

,

Nakamura

K

,

Katayama

T

,

Arahata

K

,

Takarabe

S

.

Previous Helicobacter pylori infection-induced atrophic gastritis: a distinct disease entity in an understudied population without a history of eradication

.

Helicobacter

.

2020 Feb

25

1

e12669

.

40.

Adachi

K

,

Kishi

K

,

Notsu

T

,

Mishiro

T

,

Sota

K

,

Ishimura

N

.

Serum Anti->Helicobacter pylori<> IgG antibody titer in >H. pylori<>-negative cases with a different gastric mucosal atrophy status

.

Intern Med

.

2020 Nov 15

59

22

2817

23

.

41.

Wroblewski

LE

,

Peek

RM

Jr.

Helicobacter pylori, cancer, and the gastric microbiota

.

Adv Exp Med Biol

.

2016

;

908

:

393

–

408

.

42.

Craanen

ME

,

Blok

P

,

Dekker

W

,

Ferwerda

J

,

Tytgat

GN

.

Subtypes of intestinal metaplasia and Helicobacter pylori

.

Gut

.

1992 May

33

5

597

600

.

43.

Genta

RM

,

Gürer

IE

,

Graham

DY

,

Krishnan

B

,

Segura

AM

,

Gutierrez

O

.

Adherence of Helicobacter pylori to areas of incomplete intestinal metaplasia in the gastric mucosa

.

Gastroenterology

.

1996 Nov

111

5

1206

11

.

44.

Kang

HY

,

Kim

N

,

Park

YS

,

Hwang

JH

,

Kim

JW

,

Jeong

SH

.

Progression of atrophic gastritis and intestinal metaplasia drives Helicobacter pylori out of the gastric mucosa

.

Dig Dis Sci

.

2006 Dec

51

12

2310

5

.

45.

Sáenz

JB

,

Vargas

N

,

Mills

JC

.

Tropism for spasmolytic polypeptide-expressing metaplasia allows Helicobacter pylori to expand its intragastric niche

.

Gastroenterology

.

2019 Jan

156

1

160

74

. e7.

46.

Shimizu

T

,

Choi

E

,

Petersen

CP

,

Noto

JM

,

Romero-Gallo

J

,

Piazuelo

MB

.

Characterization of progressive metaplasia in the gastric corpus mucosa of Mongolian gerbils infected with Helicobacter pylori

.

J Pathol

.

2016 Aug

239

4

399

410

.

47.

Hobsley

M

,

Tovey

FI

,

Holton

J

.

Helicobacter pylori and gastric cancer: neither friend nor foe

.

Gastroenterology

.

2007 May

132

5

2076

.

48.

Liatsos

C

,

Papaefthymiou

A

,

Kyriakos

N

,

Galanopoulos

M

,

Doulberis

M

,

Giakoumis

M

.

Helicobacter pylori, gastric microbiota and gastric cancer relationship: unrolling the tangle

.

World J Gastrointest Oncol

.

2022 May 15

14

5

959

72

.

49.

Iino

C

,

Shimoyama

T

,

Chinda

D

,

Arai

T

,

Chiba

D

,

Nakaji

S

.

Infection of Helicobacter pylori and atrophic gastritis influence Lactobacillus in gut microbiota in a Japanese population

.

Front Immunol

.

2018

;

9

:

712

.

50.

Iino

C

,

Shimoyama

T

,

Chinda

D

,

Sakuraba

H

,

Fukuda

S

,

Nakaji

S

.

Influence of Helicobacter pylori infection and atrophic gastritis on the gut microbiota in a Japanese population

.

Digestion

.

2020

;

101

(

4

):

422

–

32

.

51.

Zi

M

,

Zhang

Y

,

Hu

C

,

Zhang

S

,

Chen

J

,

Yuan

L

.

A literature review on the potential clinical implications of streptococci in gastric cancer

.

Front Microbiol

.

2022

;

13

:

1010465

.

52.

Waskito

LA

,

Rezkitha

YA

,

Vilaichone

RK

,

Sugihartono

T

,

Mustika

S

,

Dewa Nyoman Wibawa

I

.

The role of non-Helicobacter pylori bacteria in the pathogenesis of gastroduodenal diseases

.

Gut Pathog

.

2022 May 23

14

1

19

.

53.

Zhou

X

,

Su

J

,

Zhu

L

,

Zhang

G

.

Helicobacter pylori modulates cisplatin sensitivity in gastric cancer by down-regulating miR-141 expression

.

Helicobacter

.

2014 Jun

19

3

174

81

.

54.

Paoletti

X

,

Oba

K

,

Burzykowski

T

,

Michiels

S

,

Ohashi

Y

,

Pignon

JP

.

Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis

.

Jama

.

2010 May 5

303

17

1729

37

.

55.

Cao

J

,

Qi

F

,

Liu

T

.

Adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis

.

Scand J Gastroenterol

.

2014 Jun

49

6

690

704

.

56.

Ter Veer

E

,

Mohammad

NH

,

Lodder

P

,

Ngai

LL

,

Samaan

M

,

van Oijen

MGH

.

The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis

.

Gastric Cancer

.

2016 Jul

19

3

696

712

.

57.

Caruso

ML

,

Fucci

L

.

Histological identification of Helicobacter pylori in early and advanced gastric cancer

.

J Clin Gastroenterol

.

1990 Oct

12

5

601

2

.

58.

Tang

YL

,

Gan

RL

,

Dong

BH

,

Jiang

RC

,

Tang

RJ

.

Detection and location of Helicobacter pylori in human gastric carcinomas

.

World J Gastroenterol

.

2005 Mar 7

11

9

1387

91

.

59.

Wang

C

,

Yuan

Y

,

Hunt

RH

.

The association between Helicobacter pylori infection and early gastric cancer: a meta-analysis

.

Am J Gastroenterol

.

2007 Aug

102

8

1789

98

.

60.

Wang

J

,

Liu

X

.

Correlation analysis between Helicobacter pylori infection status and tumor clinical pathology as well as prognosis of gastric cancer patients

.

Iran J Public Health

.

2018 Oct

47

10

1529

36

.

61.

Kurtenkov

O

,

Klaamas

K

,

Sergeyev

B

,

Chuzmarov

V

,

Miljukhina

L

,

Shljapnikova

L

.

Better survival of Helicobacter pylori infected patients with early gastric cancer is related to a higher level of Thomsen-Friedenreich antigen-specific antibodies

.

Immunol Invest

.

2003 Feb

32

1–2

83

93

.

62.

Wang

YK

,

Kuo

FC

,

Liu

CJ

,

Wu

MC

,

Shih

HY

,

Wang

SS

.

Diagnosis of Helicobacter pylori infection: current options and developments

.

World J Gastroenterol

.

2015 Oct 28

21

40

11221

35

.

63.

Malfertheiner

P

,

Megraud

F

,

O'Morain

CA

,

Atherton

J

,

Axon

AT

,

Bazzoli

F

.

Management of Helicobacter pylori infection--the Maastricht IV/florence consensus Report

.

Gut

.

2012 May

61

5

646

64

.